Sutro Biopharma Inc buy Wedbush
Start price
23.10.23
/
50%
€2.72
Target price
23.10.24
€11.29
Performance (%)
15.44%
Price
26.04.24
€3.14
Summary
This prediction is currently active. The BUY prediction by Wedbush currently has a performance of 15.44%. This prediction currently runs until 23.10.24. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sutro Biopharma Inc | -7.101% | -7.101% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by Wedbush for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $12.00 price target on the stock.
Ratings data for STRO provided by MarketBeat
Stopped prediction by Wedbush for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.78
03.04.24
03.04.24
€7.38
03.04.25
03.04.25
-26.78%
26.04.24
26.04.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.58
26.03.24
26.03.24
€7.38
26.03.25
26.03.25
-23.58%
26.04.24
26.04.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.08
14.11.23
14.11.23
€11.07
14.11.24
14.11.24
68.27%
26.04.24
26.04.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€3.86
11.08.23
11.08.23
€10.95
11.08.24
11.08.24
-18.13%
26.04.24
26.04.24